ArticleScientific reports2025
Mechanical properties and biodegradability of samples obtained by 3D printing using FDM technology from PLA filament with by-products.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Acoustic Absorption in 3D-Printed PLA Biocomposite Models: Influence of Grid, Trihexagonal, and Gyroid Infills and Biomass Reinforcement.ACS applied engineering materials · 2026Article
- Article
- The Impact of Coloring Additives on Thermal, Mechanical, and Tribological Properties of FDM-Printed Components.Polymers · 2026Article
- Print, Eat, Heal: Unravelling the Potential of Bioactives in 3D Food Technology.Foods (Basel, Switzerland) · 2026Review
- Thermal and Chemical Characterization of Digital Light Processing (DLP)-Manufactured Polymer Composites Reinforced with Jute Fibers.Polymers · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, 3D printing has become a rapidly developing manufacturing technology with huge potential and is influencing many industries, such as engineering, art, education, medicine, aerospace, and many more. Of the many technologies, the one used most frequently is the FDM (fused deposition modeling) method, which is widely available, relatively simple and inexpensive. The essence of this method is to extrude a thermoplastic material through a heated nozzle in a controlled manner. PLA, or polylactide, is a naturally sourced material with good biodegradable properties. It is frequently used in 3D printing and is derived from natural ingredients such as maize starch or sugar cane. The current study aimed to determine the effects of adding plant-origin food industry by-products, such as carrot pomace and ground walnut shells, to PLA on the mechanical and biodegradable properties of specimens printed using the FDM technology. The assumed research objective is consistent with the issue of sustainable development in the management of by-products from the food industry. The study used a pulverized fraction of each additive, with a particle size of less than 0.2 mm, which was introduced into the base material PLA at rates of 1%, 3% and 5%. The mixtures prepared in this manner were used to print (using FDM technology) standardized specimens, which were assessed for strength (bending and breaking tests) and biodegradability (weight loss after 60 and 120 days of storage under varying climatic conditions). It was observed that the additive increased the bending strength parameters (by a maximum of 44.9%, as compared to the raw material with no additives) while decreasing the breaking stress (by a maximum of approximately 15%, as compared to the raw material with no additives). Using plant additives increased biodegradability (up to 7.6%) compared to the control material.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.